| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.936 | 8.735 | 16.719 | 28.096 | 26.529 | 24.894 | 32.895 | 37.214 | 40.486 | 48.498 |
| Total Income - EUR | 2.231 | 8.735 | 16.719 | 28.135 | 26.548 | 26.948 | 33.032 | 37.214 | 40.486 | 53.915 |
| Total Expenses - EUR | 1.950 | 2.770 | 4.939 | 2.909 | 5.040 | 6.956 | 8.489 | 7.463 | 13.876 | 15.395 |
| Gross Profit/Loss - EUR | 282 | 5.966 | 11.779 | 25.226 | 21.507 | 19.991 | 24.543 | 29.751 | 26.610 | 38.521 |
| Net Profit/Loss - EUR | 215 | 5.703 | 11.278 | 24.383 | 20.711 | 19.303 | 23.675 | 28.834 | 26.206 | 38.036 |
| Employees | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - C & A Pharm Trading Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 10.209 | 7.154 | 4.610 | 1.619 | 17 | 0 |
| Current Assets | 3.884 | 1.964 | 22.095 | 34.347 | 49.223 | 22.520 | 39.102 | 35.295 | 31.163 | 44.107 |
| Inventories | 0 | 0 | 0 | 461 | 813 | 682 | 644 | 646 | 644 | 641 |
| Receivables | 1.730 | 1.686 | 3.632 | 6.095 | 4.619 | 3.775 | 7.830 | 27.236 | 28.469 | 30.213 |
| Cash | 2.154 | 278 | 18.462 | 27.792 | 43.791 | 18.063 | 30.628 | 7.412 | 2.050 | 13.253 |
| Shareholders Funds | -4.969 | 786 | 11.337 | 31.214 | 47.106 | 19.353 | 34.513 | 28.883 | 26.254 | 38.084 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.852 | 1.179 | 10.757 | 3.133 | 12.327 | 10.322 | 9.200 | 8.031 | 4.925 | 6.023 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - C & A Pharm Trading Srl